Person-centred support programme (RESPECT intervention) for women with breast cancer treated with endocrine therapy: a feasibility study. Issue 10 (5th October 2022)

• Record Type: Journal Article
• Authors: Ahlstedt Karlsson, Susanne; Henoch, Ingela; Olofsson Bagge, Roger; Wallengren, Catarina
• Is Part Of: BMJ open. Volume 12:Issue 10(2022)
• Publication Date: 2022-10-05
• Subjects: Breast tumours -- Quality in health care -- QUALITATIVE RESEARCH; Medicine -- Research -- Periodicals; 610.72
• DOI: 10.1136/bmjopen-2022-060946
• Languages: English
• ISSNs: 2044-6055

Abstract

Abstract : Objective: The peRson-cEntred Support Programme EndoCrine Therapy intervention is a complex intervention encompassing a person-centred support programme for patients with breast cancer being treated with endocrine therapy (ET). The aim of this study was to explore the feasibility of the trial design and patient acceptability of the intervention and outcome measures and to provide data to estimate the parameters required to design the final intervention. Design: A controlled before-and-after design following the Consolidated Standards of Reporting Trials 2010 statement for feasibility trials. Setting: A surgical outpatient clinic in Sweden. Participants: Forty-one patients (aged 47–85) with breast cancer who were treated with ET. Interventions: Eligible patients were assigned to the control group or intervention group, which included individual education material, an individualised learning plan and a personalised reminder letter using a person-centred approach. The intervention could be delivered as a telephone or digital follow-up during a 12-week follow-up. Outcome measures: The aims were to determine the recruitment rate, assess the rate of retention, explore whether the intervention was delivered according to the protocol, assess the preferred form of educational support, rate of education sessions, length per education session and length between each education session, determine the distribution of education materials and assess completion rates of patient-reported instruments, including the General Self-efficacy Scale, the Quality of Care from the Patient's Perspective Questionnaire and the Memorial Symptom Assessment Scale. Results: Eighty-six per cent of the patients in the intervention group completed the intervention and questionnaires 3 months after their inclusion. The call attendance was 90%. During the intervention, the contact nurse complied with the intervention protocol. For self-efficacy, symptoms and quality of care, there were no differences in effect size between the control and intervention groups. Conclusions: This intervention seems to be feasible and acceptable among patients.